Prediction of Active Constituents in Saussureae Involucratae Herba Based on Systematic Pharmacology

YAN He-lu; HE Lan-yu; YING Xue; LI Xia; XU Hao-lun; WANG Ya-hua; ZHANG Hua; TANG Hui; CHEN Wen

doi:10.13422/j.cnki.syfjx.20181059

您当前的位置：

首页 >

文章列表页 >

Prediction of Active Constituents in Saussureae Involucratae Herba Based on Systematic Pharmacology

更新时间：2024-01-04

- Prediction of Active Constituents in Saussureae Involucratae Herba Based on Systematic Pharmacology
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 13, Pages: 166-171(2018)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20181059
  CLC： R285
- Published：2018
- 稿件说明：
移动端阅览
YAN He-lu, HE Lan-yu, YING Xue, et al. Prediction of Active Constituents in Saussureae Involucratae Herba Based on Systematic Pharmacology[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(13): 166-171.
DOI：

YAN He-lu, HE Lan-yu, YING Xue, et al. Prediction of Active Constituents in Saussureae Involucratae Herba Based on Systematic Pharmacology[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(13): 166-171. DOI： 10.13422/j.cnki.syfjx.20181059.

摘要

目的：通过系统药理学方法预测天山雪莲的活性成分，并验证预测结果。方法：在中药系统药理学分析平台（traditional Chinese medicine systems pharmacology，TCMSP）数据库收集天山雪莲中的成分，利用类药性（druglikeness，DL）筛选出活性化合物；构建化合物-靶点、靶点-疾病分类、癌症-靶点关系图，预测天山雪莲治疗疾病的机制；磺酰罗丹明B（sulforhodamine B，SRB）比色法测定不同浓度天山雪莲注射液对非小细胞肺癌A549的抑制率，酶联免疫吸附测定法（enzyme-linked immuno sorbent assay，ELISA）检测不同药物浓度处理的A549中前列腺素E2（prostaglandin E2，PGE2）的含量。结果：筛选出24种活性化合物；随药物浓度增加对A549的抑制率随之升高，抑制率在质量浓度为110 mg·L-1时最高为86.22%；不同质量浓度药物干预后，A549细胞中PGE2分泌量较无药物干预组均有不同程度的降低（P<0.05）。结论：采用系统药理学方法预测了天山雪莲作用机制，通过实验验证此预测方法比较可靠，为天山雪莲药理作用的研究提供了新的研究方法。

Abstract

Objective: To predict the active components from Saussureae Involucratae Herba by system pharmacology

and verify the prediction results. Method: Components in Saussureae Involucratae Herba were collected through the traditional Chinese medicine systems pharmacology (TCMSP) database; then active components were screened out if the druglikeness (DL) was at least 0.18.The relation graph of compounds-targets

targets-diseases and cancers-targets were constructed

so as to find the mechanisms for treating diseases with Saussureae Involucratae Herba. Next

the inhibitory effect against A549 cells was tested by SRB method. Meanwhile

the amount of prostaglandin E2 (PGE2) in A549 cells was quantified by enzyme-linked immuno sorbent assay (ELISA) kit after the treatments with the drugs at different concentrations. Result: The 24 components were screened out

and their inhibitory rates on A549 cells increased with the rise of concentration. The highest inhibitory rate was 86.22% at the concentration of about 110 mg·L-1. Compared with non-drug treated group

the amount of cellular PGE2 was decreased to different degrees (P<0.05) after the drug treatment. Conclusion: The treatment methods of Saussureae Involucratae Herba were predicted by system pharmacology

which was demonstrated to be reliable by the experiment. Therefore

this study provides a new research method for the discovery of Saussureae Involucratae Herba pharmaceutical effects.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Wenyang Sanjie Prescription on Tumor Inhibition and STAT3/HIF-1α Pathway in Lung Cancer Tumor-bearing Mice

Invasion and Metastasis Inhibition of Lung Cancer by Traditional Chinese Medicine： A Review

Mechanism of Traditional Chinese Medicine Regulating JAK/STAT Signaling Pathway to Intervene in Lung Cancer： A Review

Effect of Guiqi Yiyuan Ointment on Lewis Lung Cancer Mice by Increasing Autophagic Flux and Stabilizing PD-L1 Expression Through Regulation of ERK Signaling Pathway

Chinese Medicine Regulates Ferroptosis to Treat Lung Cancer： A Review

Related Author

WANG Xinxin

GUO Junhui

LI Honglin

ZHENG Fengyu

LI Jia

SUN Xu

ZHANG Lu

LIU Huaimin

Related Institution

Henan Province Hospital of Traditional Chinese Medicine

The Second Clinical Medical College， Henan University of Chinese Medicine

The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital

Henan Province Hospital of Traditional Chinese Medicine/The Second Affiliated Hospital of Henan University of Chinese Medicine

School of Basic Medicine， Gansu University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰